Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 2 (40%) |
| §112 only | 1 (20%) |
| No statute on record | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| THOMAS, TIMOTHY P | 2 | 26.2% | +38.3% |
| UNDERDAHL, THANE E | 1 | 59.0% | +50.0% |
| SELWANES, JOHN PAUL | 1 | 44.1% | +56.8% |
| ANDERSON, JAMES D | 1 | 55.1% | +19.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17050462 | RADIATION SENSITIVITY ENHANCING COMPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | THOMAS, TIMOTHY P | 99d overdue |
| 17937778 | RADIATION SENSITIVITY ENHANCING COMOPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | THOMAS, TIMOTHY P | 72d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17800728 | Biomarker for Predicting Prognosis of Radiotherapy for Lung Cancer | SELWANES, JOHN PAUL | 141d overdue |
| 16955699 | USE FOR PROTECTING OR MITIGATING RADIATION DAMAGE, AND FOR PREVENTING OR TREATING PULMONARY FIBROSIS | ANDERSON, JAMES D | 103d overdue |
| 17050462 | RADIATION SENSITIVITY ENHANCING COMPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | THOMAS, TIMOTHY P | 99d overdue |
| 17937778 | RADIATION SENSITIVITY ENHANCING COMOPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | THOMAS, TIMOTHY P | 72d overdue |
| 17927714 | BIOMARKER COMPOSITION FOR PREDICTING PROGNOSIS OF BRAIN DISEASE CAUSED BY MICROPLASTIC EXPOSURE AND METHOD FOR PREDICTING PROGNOSIS USING SAME | UNDERDAHL, THANE E | 4d overdue |
| Art Unit | Apps |
|---|---|
| 1614 | 2 |
| 1699 | 1 |
| 1651 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17927714 | BIOMARKER COMPOSITION FOR PREDICTING PROGNOSIS OF BRAIN DISEASE CAUSED BY MICROPLASTIC EXPOSURE AND METHOD FOR PREDICTING PROGNOSIS USING SAME | UNDERDAHL, THANE E | 1699 | §112 | Non-Final OA | 4d overdue | Pending | Nov 24, 2022 |
| 17937778 | RADIATION SENSITIVITY ENHANCING COMOPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | THOMAS, TIMOTHY P | 1614 | Other | Non-Final OA | 72d overdue | Pending | Oct 03, 2022 |
| 17800728 | Biomarker for Predicting Prognosis of Radiotherapy for Lung Cancer | SELWANES, JOHN PAUL | 1651 | §102 | Final Rejection | 141d overdue | Pending | Aug 18, 2022 |
| 17050462 | RADIATION SENSITIVITY ENHANCING COMPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | THOMAS, TIMOTHY P | 1614 | Other | Final Rejection | 99d overdue | Pending | Oct 26, 2020 |
| 16955699 | USE FOR PROTECTING OR MITIGATING RADIATION DAMAGE, AND FOR PREVENTING OR TREATING PULMONARY FIBROSIS | ANDERSON, JAMES D | 1629 | §102 | Non-Final OA | 103d overdue | Pending | Sep 29, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial